Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
about
New Strategies for the Treatment of Solid Tumors with CAR-T CellsChimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and ProspectsThe Evolution of T-cell Therapies for Solid MalignanciesCAR T Cell Therapy: A Game Changer in Cancer TreatmentCAR T cells for solid tumors: armed and ready to go?Adoptive cell therapy for sarcomaMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesTargeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Engineered T cells for cancer treatmentEmerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cellsPrecision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsTumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.Genetically modified T-cell therapy for osteosarcomaFibroblast activation protein is dispensable in the anti-influenza immune response in mice.A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in miceDepletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumorsQuantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Design and development of therapies using chimeric antigen receptor-expressing T cellsAdoptive immunotherapy for cancer.Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.Adoptive immunotherapy for cancer or viruses.CD28z CARs and armored CARsCAR T-cell therapy: toxicity and the relevance of preclinical models.Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.CAR T-cell immunotherapy: The path from the by-road to the freeway?T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Novel immunotherapies for the treatment of melanoma.Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy.Chimeric antigen receptor-engineered T cells for liver cancers, progress and obstacles.Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment.Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinomaSpatial heterogeneity in medulloblastoma.T cells redirected to interleukin-13Rα2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1
P2860
Q26748500-21DB87EE-8E6C-45DB-A319-92ADF45B7ED5Q26753082-A84017AF-A949-4E42-BF57-6475AB852DE5Q26799372-863FDA4B-F5E0-4FBE-96F5-A91100334E56Q26822769-71B6DF1A-45B9-473B-AC3A-9523556FA379Q26825489-1BF5C911-A62F-4BE1-A6A7-60D03D11EAC9Q27009541-87005324-51BC-4EDC-B58D-C7E5F79FF8A0Q28073613-DB3381DD-53DA-4028-94F4-8B98AD3326D8Q28395597-524788CE-E6F3-482F-BB8B-DE16A64F093BQ33555573-EBCF296F-8B88-43F2-A075-7221620A2D28Q33578792-F72A69FA-B98F-4E73-B791-42007E22B24BQ33833475-C5BD6A8C-3502-42B7-B2A0-47794B3CAC24Q34046041-EBAA2047-2B89-4722-ACBF-D5954C967274Q35591391-99F71E5F-29D1-4CC6-ABA4-3ECB6D0E5806Q35862799-AAF552D7-1253-4E2B-8FCD-5AE3C96EA610Q36198232-B0BAD2B3-BDB9-4C91-B25D-EF2B505345A0Q36269734-2094E93E-AF9E-48A0-B8D8-5F235049F651Q36470281-5F45C7EA-1CC7-4CA3-8864-E8FE15E38780Q37268993-C58E764E-8981-4974-80BB-DF403FA3A296Q37410661-1D6A9E28-1BFC-407B-9045-74D5FD7ACDDAQ37418289-166E72E9-3113-482A-9F54-01D94409BBA1Q38170496-8EE6AF88-D273-45B6-B3F5-7C7DE26DFD57Q38170500-985F2234-28C0-4456-9FFF-A2FB3B0A8732Q38178359-E6F11F5D-8102-4A34-BB92-D00D67566958Q38199347-32D6831B-1EA4-4450-9988-4D01B0A12071Q38525018-ABD335BA-42B6-49DB-BDD0-34CB22D96256Q38525034-EFEF367C-1613-4037-9CC0-B2C11D3CF581Q38608986-5A02FD3F-804B-40FF-BA43-010BE311645BQ38632105-F246B574-46D7-4CB8-81EB-0F70E684E0CAQ38648630-CB3F1951-B5F1-47BB-B9FF-A2B0ABED79DFQ38769271-950DC014-BAEB-40B2-86E2-55CF38A460F8Q38770555-AA94852D-506E-4B77-B0E6-6251FB8D00C9Q38795935-357A9ABF-D82B-4E02-9D46-C740DD1190A2Q38824190-9EAF5946-0B8D-4A0C-A498-EA0B550B322BQ38845254-A70A68E0-5A39-4409-B79A-73D031BBED1FQ38873430-85647424-C6C7-4DF7-BA18-664D27FEE961Q38916346-E0D7B4E1-8365-444C-8595-E287BCC94A7CQ39194733-C7E389F7-BED9-4600-943C-C8A144C75FFAQ39924228-7F98FA63-EA81-4C1C-A574-B1739BCA2276Q41969132-03A473CE-29F0-4197-A026-7F351AF59D32Q42114926-B87C89A2-FACF-4DDF-92AE-786BAB8EFFA0
P2860
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@en
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@nl
type
label
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@en
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@nl
prefLabel
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@en
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@nl
P2093
P2860
P356
P1433
P1476
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
@en
P2093
David R Rowley
Donald R Shaffer
Kevin K H Chow
Klaus Pfizenmaier
Lisa L Wang
Melinda Mata
Meng-Fen Wu
Stephen Gottschalk
Sunitha Kakarla
P2860
P304
P356
10.1038/MT.2013.110
P577
2013-06-04T00:00:00Z